• AICAR reduces RAD52 foci formation and inhibits SSA activity.• AICAR reduces growth of BRCA1-mutated breast and BRCA2-mutated pancreatic cancer cells by inducing synthetic lethality.IC50 = 2-20 μM. This evidence concerns the gene RAD52 and pancreatic neoplasm.